Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated.

Torroella-Kouri M, Silvera R, Rodriguez D, Caso R, Shatry A, Opiela S, Ilkovitch D, Schwendener RA, Iragavarapu-Charyulu V, Cardentey Y, Strbo N, Lopez DM.

Cancer Res. 2009 Jun 1;69(11):4800-9. doi: 10.1158/0008-5472.CAN-08-3427. Epub 2009 May 19.

2.

Blood monocytes from mammary tumor-bearing mice: early targets of tumor-induced immune suppression?

Caso R, Silvera R, Carrio R, Iragavarapu-Charyulu V, Gonzalez-Perez RR, Torroella-Kouri M.

Int J Oncol. 2010 Oct;37(4):891-900.

PMID:
20811711
3.
4.
5.

Alterations in macrophages and monocytes from tumor-bearing mice: evidence of local and systemic immune impairment.

Torroella-Kouri M, Rodríguez D, Caso R.

Immunol Res. 2013 Dec;57(1-3):86-98. doi: 10.1007/s12026-013-8438-3. Review.

PMID:
24203436
6.
7.

IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.

Torroella-Kouri M, Keith JC, Ivanova M, Lopez DM.

Int J Oncol. 2003 Feb;22(2):439-48.

PMID:
12527946
8.

Role of the proteasome in the downregulation of transcription factors NFkappaB and C/EBP in macrophages from tumor hosts.

Perry G, Iragavarapu-Charyulu V, Harhaj EW, Torroella-Kouri M.

Oncol Rep. 2010 Mar;23(3):875-81.

PMID:
20127032
9.

IFITM6 expression is increased in macrophages of tumor-bearing mice.

Han JH, Lee S, Park YS, Park JS, Kim KY, Lim JS, Oh KS, Yang Y.

Oncol Rep. 2011 Feb;25(2):531-6. doi: 10.3892/or.2010.1092. Epub 2010 Dec 10.

PMID:
21165565
10.

Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model.

Na YR, Yoon YN, Son DI, Seok SH.

PLoS One. 2013 May 7;8(5):e63451. doi: 10.1371/journal.pone.0063451. Print 2013.

11.
12.

Tumor microenvironment profoundly modifies functional status of macrophages: peritoneal and tumor-associated macrophages are two very different subpopulations.

Rodríguez D, Silvera R, Carrio R, Nadji M, Caso R, Rodríguez G, Iragavarapu-Charyulu V, Torroella-Kouri M.

Cell Immunol. 2013 May-Jun;283(1-2):51-60. doi: 10.1016/j.cellimm.2013.06.008. Epub 2013 Jun 19.

13.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
14.

Tissue inhibitor of metalloproteinases-3 moderates the proinflammatory status of macrophages.

Gill SE, Gharib SA, Bench EM, Sussman SW, Wang RT, Rims C, Birkland TP, Wang Y, Manicone AM, McGuire JK, Parks WC.

Am J Respir Cell Mol Biol. 2013 Nov;49(5):768-77. doi: 10.1165/rcmb.2012-0377OC.

15.

Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.

Owen JL, Torroella-Kouri M, Iragavarapu-Charyulu V.

Int J Mol Med. 2008 Jan;21(1):125-34.

PMID:
18097625
16.

Tumor-promoting effect of IL-23 in mammary cancer mediated by infiltration of M2 macrophages and neutrophils in tumor microenvironment.

Nie W, Yu T, Sang Y, Gao X.

Biochem Biophys Res Commun. 2017 Jan 22;482(4):1400-1406. doi: 10.1016/j.bbrc.2016.12.048. Epub 2016 Dec 10.

PMID:
27956175
17.

An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis.

Zabuawala T, Taffany DA, Sharma SM, Merchant A, Adair B, Srinivasan R, Rosol TJ, Fernandez S, Huang K, Leone G, Ostrowski MC.

Cancer Res. 2010 Feb 15;70(4):1323-33. doi: 10.1158/0008-5472.CAN-09-1474. Epub 2010 Feb 9.

18.

M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells.

Heusinkveld M, de Vos van Steenwijk PJ, Goedemans R, Ramwadhdoebe TH, Gorter A, Welters MJ, van Hall T, van der Burg SH.

J Immunol. 2011 Aug 1;187(3):1157-65. doi: 10.4049/jimmunol.1100889. Epub 2011 Jun 27.

19.

Interleukin-12p35 deletion promotes CD4 T-cell-dependent macrophage differentiation and enhances angiotensin II-Induced cardiac fibrosis.

Li Y, Zhang C, Wu Y, Han Y, Cui W, Jia L, Cai L, Cheng J, Li H, Du J.

Arterioscler Thromb Vasc Biol. 2012 Jul;32(7):1662-74. doi: 10.1161/ATVBAHA.112.249706. Epub 2012 May 3.

20.

Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages.

Abumaree MH, Al Jumah MA, Kalionis B, Jawdat D, Al Khaldi A, Abomaray FM, Fatani AS, Chamley LW, Knawy BA.

Stem Cell Rev. 2013 Oct;9(5):620-41. doi: 10.1007/s12015-013-9455-2.

PMID:
23812784

Supplemental Content

Support Center